Brief: Avalon Reports Successful Completion Of Phase I Study Of Car T-Cell Therapy Candidate

Change Agents

29/06/2020 14:32

June 29 (Reuters) - Avalon Globocare Corp  AVCO.O :
    * AVALON GLOBOCARE ANNOUNCES SUCCESSFUL COMPLETION OF PHASE
I
CLINICAL STUDY OF CAR T-CELL THERAPY CANDIDATE AVA-001
    * AVALON GLOBOCARE CORP - TREATMENT WITH AVA-001 WAS
GENERALLY
WELL TOLERATED WITH MINIMAL TOXICITIES AND ADVERSE SIDE EFFECTS
    * AVALON GLOBOCARE CORP - WILL PRESENT RESULTS OF THIS
AVA-001
PHASE 1 CLINICAL TRIAL ON JULY 11,2020

Source text for Eikon:  ID:nGNX3WvzN9 
Further company coverage:  AVCO.O 

 ((Reuters.Briefs@thomsonreuters.com;))